Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Femtosecond laser-assisted arcuate keratotomy at the time of cataract surgery for the management of preexisting astigmatism.

Visco DM, Bedi R, Packer M.

J Cataract Refract Surg. 2019 Dec;45(12):1762-1769. doi: 10.1016/j.jcrs.2019.08.002.

2.

Maternal exposure to busulfan reduces the cell number in the somatosensory cortex associated with delayed somatic and reflex maturation in neonatal rats.

Gouveia HJCB, Manhães-de-Castro R, Costa-de-Santana BJR, Mendonça CR, Albuquerque G, Visco DB, Lacerda DC, Toscano AE.

J Chem Neuroanat. 2020 Jan;103:101710. doi: 10.1016/j.jchemneu.2019.101710. Epub 2019 Nov 7.

PMID:
31706849
3.

A Validity Study Applying the Rasch Model to the American Association for the Advancement of Science Force and Motion Sub-Topic Assessment for Middle School Students.

Koskey KLK, Makki N, Ahmed W, Garafolo NG, Visco DP Jr, Kruggel BG, Halasa K.

J Appl Meas. 2019;20(3):243-258.

PMID:
31390601
4.

Virtual high-throughput screens identifying hPK-M2 inhibitors: Exploration of model extrapolation.

Chen JJ, Schmucker LN, Visco DP Jr.

Comput Biol Chem. 2019 Feb;78:317-329. doi: 10.1016/j.compbiolchem.2018.12.006. Epub 2018 Dec 23.

PMID:
30623877
5.

Identifying de-NEDDylation inhibitors: Virtual high-throughput screens targeting SENP8.

Chen JJ, Schmucker LN, Visco DP Jr.

Chem Biol Drug Des. 2019 Apr;93(4):590-604. doi: 10.1111/cbdd.13457. Epub 2019 Feb 12.

PMID:
30560590
6.

Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review.

Visco DB, Manhães-de-Castro R, Chaves WF, Lacerda DC, Pereira SDC, Ferraz-Pereira KN, Toscano AE.

Pharmacol Res. 2018 Oct;136:194-204. doi: 10.1016/j.phrs.2018.09.004. Epub 2018 Sep 6.

PMID:
30196103
7.

Identifying new clotting factor XIa inhibitors in virtual high-throughput screens using PCA-GA-SVM models and signature.

Chen JJ, Schmucker LN, Visco DP Jr.

Biotechnol Prog. 2018 Nov;34(6):1553-1565. doi: 10.1002/btpr.2693. Epub 2018 Sep 27.

PMID:
30009405
8.
9.

Effect of phenylephrine/ketorolac on iris fixation ring use and surgical times in patients at risk of intraoperative miosis.

Visco D.

Clin Ophthalmol. 2018 Feb 5;12:301-305. doi: 10.2147/OPTH.S149522. eCollection 2018.

10.

Identifying novel factor XIIa inhibitors with PCA-GA-SVM developed vHTS models.

Chen JJF, Visco DP Jr.

Eur J Med Chem. 2017 Nov 10;140:31-41. doi: 10.1016/j.ejmech.2017.08.056. Epub 2017 Sep 1.

PMID:
28918098
11.

Perinatal undernutrition associated to experimental model of cerebral palsy increases adverse effects on chewing in young rats.

Lacerda DC, Ferraz-Pereira KN, Visco DB, Pontes PB, Chaves WF, Guzman-Quevedo O, Manhães-de-Castro R, Toscano AE.

Physiol Behav. 2017 May 1;173:69-78. doi: 10.1016/j.physbeh.2017.01.043. Epub 2017 Jan 30.

PMID:
28153456
12.

Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.

Debenham JS, Madsen-Duggan C, Clements MJ, Walsh TF, Kuethe JT, Reibarkh M, Salowe SP, Sonatore LM, Hajdu R, Milligan JA, Visco DM, Zhou D, Lingham RB, Stickens D, DeMartino JA, Tong X, Wolff M, Pang J, Miller RR, Sherer EC, Hale JJ.

J Med Chem. 2016 Dec 22;59(24):11039-11049. doi: 10.1021/acs.jmedchem.6b01242. Epub 2016 Nov 30.

PMID:
28002958
13.

Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris.

Nett JH, Gomathinayagam S, Hamilton SR, Gong B, Davidson RC, Du M, Hopkins D, Mitchell T, Mallem MR, Nylen A, Shaikh SS, Sharkey N, Barnard GC, Copeland V, Liu L, Evers R, Li Y, Gray PM, Lingham RB, Visco D, Forrest G, DeMartino J, Linden T, Potgieter TI, Wildt S, Stadheim TA, d'Anjou M, Li H, Sethuraman N.

J Biotechnol. 2012 Jan;157(1):198-206. doi: 10.1016/j.jbiotec.2011.11.002. Epub 2011 Nov 9.

PMID:
22100268
14.

The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the dog.

Cook JL, Kuroki K, Visco D, Pelletier JP, Schulz L, Lafeber FP.

Osteoarthritis Cartilage. 2010 Oct;18 Suppl 3:S66-79. doi: 10.1016/j.joca.2010.04.017.

15.

You never know what you might find--tracheo-esophageal fistula from extrusion of a spinal fusion fixation screw.

Hoag JB, Visco DP, Lund ME.

Respiration. 2010;79(6):506-7. doi: 10.1159/000192369. Epub 2009 Jan 9. No abstract available.

16.

Potential glucocorticoid receptor ligands with pulmonary selectivity using I-QSAR with the signature molecular descriptor.

Jackson JD, Weis DC, Visco DP Jr.

Chem Biol Drug Des. 2008 Dec;72(6):540-50. doi: 10.1111/j.1747-0285.2008.00732.x.

PMID:
19090921
17.

Data mining PubChem using a support vector machine with the Signature molecular descriptor: classification of factor XIa inhibitors.

Weis DC, Visco DP Jr, Faulon JL.

J Mol Graph Model. 2008 Nov;27(4):466-75. doi: 10.1016/j.jmgm.2008.08.004. Epub 2008 Aug 27.

PMID:
18829357
18.

Discovery of betamethasone 17alpha-carbamates as dissociated glucocorticoid receptor modulators in the rat.

Ali A, Balkovec JM, Greenlee M, Hammond ML, Rouen G, Taylor G, Einstein M, Ge L, Harris G, Kelly TM, Mazur P, Pandit S, Santoro J, Sitlani A, Wang C, Williamson J, Forrest MJ, Carballo-Jane E, Luell S, Lowitz K, Visco D.

Bioorg Med Chem. 2008 Aug 15;16(16):7535-42. doi: 10.1016/j.bmc.2008.07.037. Epub 2008 Jul 20.

PMID:
18691892
19.

Chemical genetics define the roles of p38alpha and p38beta in acute and chronic inflammation.

O'Keefe SJ, Mudgett JS, Cupo S, Parsons JN, Chartrain NA, Fitzgerald C, Chen SL, Lowitz K, Rasa C, Visco D, Luell S, Carballo-Jane E, Owens K, Zaller DM.

J Biol Chem. 2007 Nov 30;282(48):34663-71. Epub 2007 Sep 13.

20.

Association patterns in (HF)(m)(H2O)(n) (m + n = 2-8) clusters.

Baburao B, Visco DP Jr, Albu TV.

J Phys Chem A. 2007 Aug 16;111(32):7940-56. Epub 2007 Jul 17.

PMID:
17636970
21.

Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis.

Santora K, Rasa C, Visco D, Steinetz BG, Bagnell CA.

J Pharmacol Exp Ther. 2007 Aug;322(2):887-93. Epub 2007 May 25.

PMID:
17526806
22.

Isothermal compressibility maxima of hydrogen fluoride in the supercritical and superheated vapor regions.

Baburao B, Visco DP Jr.

J Phys Chem B. 2006 Dec 28;110(51):26204-10.

PMID:
17181277
23.

p38 MAP kinase inhibitors. Part 5: discovery of an orally bio-available and highly efficacious compound based on the 7-amino-naphthyridone scaffold.

Natarajan SR, Liu L, Levorse M, Thompson JE, O'Neill EA, O'Keefe SJ, Vora KA, Cvetovich R, Chung JY, Carballo-Jane E, Visco DM.

Bioorg Med Chem Lett. 2006 Oct 15;16(20):5468-71. Epub 2006 Sep 1.

PMID:
16945534
24.

Evaluation of a potential stress effect in rat adjuvant arthritis by using a new and efficient plethysmograph.

Rasa CG, Wismer MK, Kath GS, Santora KA, Widmer RW, Visco DM.

J Am Assoc Lab Anim Sci. 2006 May;45(3):45-50.

PMID:
16642970
25.

Effects of relaxin in a model of rat adjuvant-induced arthritis.

Santora K, Rasa C, Visco D, Steinetz B, Bagnell C.

Ann N Y Acad Sci. 2005 May;1041:481-5.

PMID:
15956749
26.

Impulse penetration into idealized granular beds: behavior of cumulative surface kinetic energy.

Visco DP Jr, Swaminathan S, Mohan TR, Sokolow A, Sen S.

Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Nov;70(5 Pt 1):051306. Epub 2004 Nov 15.

PMID:
15600602
27.

The signature molecular descriptor. 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides.

Churchwell CJ, Rintoul MD, Martin S, Visco DP Jr, Kotu A, Larson RS, Sillerud LO, Brown DC, Faulon JL.

J Mol Graph Model. 2004 Mar;22(4):263-73.

PMID:
15177078
29.

The signature molecular descriptor. 2. Enumerating molecules from their extended valence sequences.

Faulon JL, Churchwell CJ, Visco DP Jr.

J Chem Inf Comput Sci. 2003 May-Jun;43(3):721-34.

PMID:
12767130
30.

The signature molecular descriptor. 1. Using extended valence sequences in QSAR and QSPR studies.

Faulon JL, Visco DP Jr, Pophale RS.

J Chem Inf Comput Sci. 2003 May-Jun;43(3):707-20.

PMID:
12767129
31.

Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile.

Leblanc Y, Roy P, Wang Z, Li CS, Chauret N, Nicoll-Griffith DA, Silva JM, Aubin Y, Yergey JA, Chan CC, Riendeau D, Brideau C, Gordon R, Xu L, Webb J, Visco DM, Prasit P.

Bioorg Med Chem Lett. 2002 Nov 18;12(22):3317-20.

PMID:
12392741
32.

Developing a methodology for an inverse quantitative structure-activity relationship using the signature molecular descriptor.

Visco DP Jr, Pophale RS, Rintoul MD, Faulon JL.

J Mol Graph Model. 2002 Jun;20(6):429-38.

PMID:
12071277
33.

Diagnostic tools you can't afford to ignore.

Visco DM.

Med Econ. 2001 Sep 17;78(18):70, 73. No abstract available.

PMID:
11601171
34.

Relaxation of classical particles in two-dimensional anharmonic single-well potentials.

Visco DP Jr, Sen S.

Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Feb;63(2 Pt 1):021114. Epub 2001 Jan 26.

PMID:
11308475
35.

Use of telehealth for chronic wound care: a case study.

Visco DC, Shalley T, Wren SJ, Pieri Flynn J, Brem H, Kerstein MD, Fitzpatrick JJ.

J Wound Ostomy Continence Nurs. 2001 Mar;28(2):89-95.

PMID:
11248729
36.

Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

Riendeau D, Percival MD, Brideau C, Charleson S, Dubé D, Ethier D, Falgueyret JP, Friesen RW, Gordon R, Greig G, Guay J, Mancini J, Ouellet M, Wong E, Xu L, Boyce S, Visco D, Girard Y, Prasit P, Zamboni R, Rodger IW, Gresser M, Ford-Hutchinson AW, Young RN, Chan CC.

J Pharmacol Exp Ther. 2001 Feb;296(2):558-66.

PMID:
11160644
37.

Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors.

Lau CK, Brideau C, Chan CC, Charleson S, Cromlish WA, Ethier D, Gauthier JY, Gordon R, Guay J, Kargman S, Li CS, Prasit P, Riendeau D, Thérien M, Visco DM, Xu L.

Bioorg Med Chem Lett. 1999 Nov 15;9(22):3187-92.

PMID:
10576685
38.

A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors.

Li CS, Black WC, Brideau C, Chan CC, Charleson S, Cromlish WA, Claveau D, Gauthier JY, Gordon R, Greig G, Grimm E, Guay J, Lau CK, Riendeau D, Thérien M, Visco DM, Wong E, Xu L, Prasit P.

Bioorg Med Chem Lett. 1999 Nov 15;9(22):3181-6.

PMID:
10576684
39.

Serial force plate analyses of dogs with unilateral knee instability, with or without interruption of the sensory input from the ipsilateral limb.

O'Connor BL, Visco DM, Rogers PI, Mamlin LA, Brandt KD.

Osteoarthritis Cartilage. 1999 Nov;7(6):567-73.

40.

SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor.

Leblanc Y, Roy P, Boyce S, Brideau C, Chan CC, Charleson S, Gordon R, Grimm E, Guay J, Léger S, Li CS, Riendeau D, Visco D, Wang Z, Webb J, Xu LJ, Prasit P.

Bioorg Med Chem Lett. 1999 Aug 2;9(15):2207-12.

PMID:
10465547
41.

2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors.

Black WC, Brideau C, Chan CC, Charleson S, Chauret N, Claveau D, Ethier D, Gordon R, Greig G, Guay J, Hughes G, Jolicoeur P, Leblanc Y, Nicoll-Griffith D, Ouimet N, Riendeau D, Visco D, Wang Z, Xu L, Prasit P.

J Med Chem. 1999 Apr 8;42(7):1274-81.

PMID:
10197970
42.

Effect of hydration on signal intensity of gelatin phantoms using low-field magnetic resonance imaging: possible application in osteoarthritis.

Baird DK, Kincaid SA, Hathcock JT, Rumph PF, Kammerman J, Visco DM.

Vet Radiol Ultrasound. 1999 Jan-Feb;40(1):27-35.

PMID:
10023992
43.

2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors.

Friesen RW, Brideau C, Chan CC, Charleson S, Deschênes D, Dubé D, Ethier D, Fortin R, Gauthier JY, Girard Y, Gordon R, Greig GM, Riendeau D, Savoie C, Wang Z, Wong E, Visco D, Xu LJ, Young RN.

Bioorg Med Chem Lett. 1998 Oct 6;8(19):2777-82.

PMID:
9873621
44.

Pyrroles and other heterocycles as inhibitors of p38 kinase.

de Laszlo SE, Visco D, Agarwal L, Chang L, Chin J, Croft G, Forsyth A, Fletcher D, Frantz B, Hacker C, Hanlon W, Harper C, Kostura M, Li B, Luell S, MacCoss M, Mantlo N, O'Neill EA, Orevillo C, Pang M, Parsons J, Rolando A, Sahly Y, Sidler K, O'Keefe SJ, et al.

Bioorg Med Chem Lett. 1998 Oct 6;8(19):2689-94.

PMID:
9873604
45.

Low-field magnetic resonance imaging of early subchondral cyst-like lesions in induced cranial cruciate ligament deficient dogs.

Baird DK, Hathcock JT, Kincaid SA, Rumph PF, Kammermann J, Widmer WR, Visco D, Sweet D.

Vet Radiol Ultrasound. 1998 May-Jun;39(3):167-73.

PMID:
9634181
46.

Low-field magnetic resonance imaging of the canine stifle joint: normal anatomy.

Baird DK, Hathcock JT, Rumph PF, Kincaid SA, Visco DM.

Vet Radiol Ultrasound. 1998 Mar-Apr;39(2):87-97.

PMID:
9548134
47.

Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis.

Singer II, Scott S, Kawka DW, Bayne EK, Weidner JR, Williams HR, Mumford RA, Lark MW, McDonnell J, Christen AJ, Moore VL, Mudgett JS, Visco DM.

Osteoarthritis Cartilage. 1997 Nov;5(6):407-18.

48.
49.

Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction.

Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, Bayne EK, Flanagan J, Kawka D, Shen CF, Stevens K, Chen H, Trumbauer M, Visco DM.

Arthritis Rheum. 1998 Jan;41(1):110-21.

PMID:
9433876
50.

Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.

Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK, et al.

J Med Chem. 1997 Mar 14;40(6):1026-40.

PMID:
9083493

Supplemental Content

Support Center